Shots:

• ResistancePlus MG FleXible is used for Cepheid GeneXpert System diagnosing STI Mycoplasma genitalium (Mgen) and markers associated with azithromycin resistance currently approved for sales in EU
• SpeeDx collaborated with Cepheid providing Resistance Guided Therapy for Mgen on the GeneXpert sample-to-answer ResistancePlus MG FleXible assay- the first test to be launched in Cepheid’s FleXible Cartridge program. Cepheid will be responsible for distribution of the assay
• The assay is open-platform easy-to-use on demand format approved for sales in EU as well as in Australia and is expected for the US FDA submission. Additionally- SpeeDx offers technology for simultaneous detection of pathogens and drug resistance directly from clinical specimens

Click here to read full press release/ article | Ref: Business Wire | Image: Behance